Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Ph II oral BGJ398 in pts w/ adv/ met cholangiocarcinoma w/ FGFR2 gene fusions/alterations.

Protocol: OSU-14106

Full Title

A phase II multicenter, single arm study of oral BGJ398 in adult patients with advanced or metastatic cholangiocarcinoma with FGFR2 gene fusions or other FGFR genetic alterations who failed or are intolerant to platinum-based chemotherapy